Prevalence of antiplatelet therapy in patients with diabetes.

作者: Shaun R Miller , Benjamin Littenberg , Charles D MacLean

DOI: 10.1186/1475-2840-4-18

关键词:

摘要: Objective To determine the prevalence of, and patient characteristics associated with, antiplatelet therapy in a cohort of primary care patients with Type 1 or Type2 diabetes.

参考文章(39)
Lisa A. Faulkner, Helen Halpin Schauffler, The Effect of Health Insurance Coverage on the Appropriate Use of Recommended Clinical Preventive Services American Journal of Preventive Medicine. ,vol. 13, pp. 453- 458 ,(1997) , 10.1016/S0749-3797(18)30141-7
David M Capuzzi, John M Morgan, Hypercholesterolemia. The NCEP Adult Treatment Panel III Guidelines. Geriatrics. ,vol. 58, pp. 33- 38 ,(2003)
Duncan Short, Martin Frischer, James Bashford, Darren Ashcroft, Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement BMC Family Practice. ,vol. 4, pp. 9- 9 ,(2003) , 10.1186/1471-2296-4-9
Stephen D. Persell, David W. Baker, Aspirin Use Among Adults With Diabetes Archives of Internal Medicine. ,vol. 164, pp. 2492- 2499 ,(2004) , 10.1001/ARCHINTE.164.22.2492
Candi Nobles-James, Erskine A. James, James R. Sowers, Prevention of cardiovascular complications of diabetes mellitus by aspirin. Cardiovascular Drug Reviews. ,vol. 22, pp. 215- 226 ,(2006) , 10.1111/J.1527-3466.2004.TB00142.X
A. Filippi, A. Sabatini, L. Badioli, F. Samani, G. Mazzaglia, A. Catapano, C. Cricelli, Effects of an automated electronic reminder in changing the antiplatelet drug-prescribing behavior among Italian general practitioners in diabetic patients: an intervention trial. Diabetes Care. ,vol. 26, pp. 1497- 1500 ,(2003) , 10.2337/DIACARE.26.5.1497